Is BMY up or down today?
BMY is down 0.17% today, last at 63.64. This stock moved -0.17% versus the prior close.
BMY · Bristol Myers Squibb
BMY (Bristol Myers Squibb) is trading at 63.64, down 0.17% on the session. BMY sits at the 81% mark of its 52-week range, carries a 14-day RSI of 42, and trades above its 50-day average. Over the past month it is up 0.05%.
Leading the coverage: “Bristol Myers’ Cancer Therapy Win Strengthens its Oncology Pipeline” (Yahoo, 8h ago).
BMY trades on a trailing P/E of 13.9 and is running 0.86% ahead of the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
BMY is down 0.17% today, last at 63.64. This stock moved -0.17% versus the prior close.
Leading the coverage: “Bristol Myers’ Cancer Therapy Win Strengthens its Oncology Pipeline” (Yahoo, 8h ago). Dominant story: Bristol Myers’ Cancer Therapy Win Strengthens its Oncology Pipeline (1 source, neutral) RSI is 42 — leaning bearish Price above 50-day average — short-term uptrend Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: Mar 2026 – Sep 2026 (125 days) · Drag or scroll left for earlier dates
Bristol Myers’ Cancer Therapy Win Strengthens its Oncology Pipeline
Bristol Myers Squibb stock edges lower as options activity and new price targets test 2026 guidance - ad-hoc-news.de
Why is Bristol Myers Squibb (NYSE:BMY) stock in focus today? - Kalkine Media
Bristol Myers Squibb (BMY) Faces Fresh Patent Pressure In Cardiac Drug Fight - simplywall.st
Bristol Myers Squibb stock heads into the open after a 1.0% drop - ad-hoc-news.de